Editorial: Novel and potential biomarkers for prediction of outcome in patients with chronic and acute coronary heart disease, volume II.
作者信息
Nilsen Dennis W T, Kontny Frederic, Ten Cate Hugo
机构信息
Department of Cardiology, Stavanger University Hospital, Stavanger, Norway.
Department of Clinical Science, University of Bergen, Bergen, Norway.
出版信息
Front Cardiovasc Med. 2024 May 28;11:1432580. doi: 10.3389/fcvm.2024.1432580. eCollection 2024.
Abstract
摘要
相似文献
1
Editorial: Novel and potential biomarkers for prediction of outcome in patients with chronic and acute coronary heart disease, volume II.
Front Cardiovasc Med. 2024 May 28;11:1432580. doi: 10.3389/fcvm.2024.1432580. eCollection 2024.
2
Editorial: Novel and potential markers for prediction of outcome in patients with acute and chronic coronary heart disease.
Front Cardiovasc Med. 2019 May 22;6:66. doi: 10.3389/fcvm.2019.00066. eCollection 2019.
3
Biomarkers and cardiovascular events in patients with stable coronary disease in the ISCHEMIA Trials.
Am Heart J. 2023 Dec;266:61-73. doi: 10.1016/j.ahj.2023.08.007. Epub 2023 Aug 19.
4
Emerging families of biomarkers for coronary artery disease: inflammatory mediators.
Vasc Health Risk Manag. 2013;9:435-56. doi: 10.2147/VHRM.S45704. Epub 2013 Jul 31.
5
Prognostic significance of metabolomic biomarkers in patients with diabetes mellitus and coronary artery disease.
Cardiovasc Diabetol. 2022 May 7;21(1):70. doi: 10.1186/s12933-022-01494-9.
6
Cardio-Renal Biomarker Soluble Urokinase-Type Plasminogen Activator Receptor Is Associated With Cardiovascular Death and Myocardial Infarction in Patients With Coronary Artery Disease Independent of Troponin, C-Reactive Protein, and Renal Function.
J Am Heart Assoc. 2020 Apr 21;9(8):e015452. doi: 10.1161/JAHA.119.015452. Epub 2020 Apr 17.
7
Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary disease.
Circulation. 2012 Jan 17;125(2):233-40. doi: 10.1161/CIRCULATIONAHA.111.063842. Epub 2011 Dec 16.
8
Prognostic value of 12 novel cardiological biomarkers in stable coronary artery disease. A 10-year follow-up of the placebo group of the Copenhagen CLARICOR trial.
BMJ Open. 2020 Aug 20;10(8):e033720. doi: 10.1136/bmjopen-2019-033720.
9
Biomarker-Based Prediction of Recurrent Ischemic Events in Patients With Acute Coronary Syndromes.
J Am Coll Cardiol. 2022 Nov 1;80(18):1735-1747. doi: 10.1016/j.jacc.2022.08.767.
10
Impact of Chronic Kidney Disease on the Associations of Cardiovascular Biomarkers With Adverse Outcomes in Patients With Suspected or Known Coronary Artery Disease: The EXCEED-J Study.
J Am Heart Assoc. 2022 Feb;11(3):e023464. doi: 10.1161/JAHA.121.023464. Epub 2022 Jan 20.
本文引用的文献
1
D-dimer testing: A narrative review.
Adv Clin Chem. 2023;114:151-223. doi: 10.1016/bs.acc.2023.02.006. Epub 2023 Mar 29.
2
Dual pathway inhibition in patients with atherosclerotic disease: pharmacodynamic considerations and clinical implications.
Expert Rev Clin Pharmacol. 2023 Jan;16(1):27-38. doi: 10.1080/17512433.2023.2154651. Epub 2022 Dec 12.
3
Clinical use of thrombin generation assays.
J Thromb Haemost. 2021 Dec;19(12):2918-2929. doi: 10.1111/jth.15538. Epub 2021 Oct 8.
4
Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease.
Circ Res. 2021 May 28;128(11):1728-1746. doi: 10.1161/CIRCRESAHA.121.319077. Epub 2021 May 17.
5
Plasma Biomarkers to Predict Cardiovascular Outcome in Patients With Peripheral Artery Disease: A Systematic Review and Meta-Analysis.
Arterioscler Thromb Vasc Biol. 2020 Sep;40(9):2018-2032. doi: 10.1161/ATVBAHA.120.314774. Epub 2020 Jul 9.
6
The ABC death risk score: is it time to start measuring GDF-15?
Eur Heart J. 2018 Feb 7;39(6):486-487. doi: 10.1093/eurheartj/ehx642.
7
Prognostic Value of Circulating Inflammatory Cells in Patients with Stable and Acute Coronary Artery Disease.
Front Cardiovasc Med. 2017 Jul 14;4:44. doi: 10.3389/fcvm.2017.00044. eCollection 2017.
Zotero 插件